# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001129928-18-000028
Filing Date
2018-03-19
Accepted
2018-03-19 16:37:54
Documents
101
Period of Report
2017-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | oncyf2017-20f.htm | 20-F | 1688294
2 | EXHIBIT 4.43 | ex443deguttadauro.htm | EX-4.43 | 75519
3 | EXHIBIT 4.44 | ex444regionallicensingagre.htm | EX-4.44 | 665112
4 | EXHIBIT 4.45 | ex445coffey.htm | EX-4.45 | 16274
5 | EXHIBIT 4.46 | ex446look.htm | EX-4.46 | 15742
6 | EXHIBIT 4.47 | ex447deguttadauro.htm | EX-4.47 | 17317
7 | EXHIBIT 4.48 | ex448gutierrez.htm | EX-4.48 | 17140
8 | EXHIBIT 8.0 | ex80subsidiaries2017.htm | EX-8.0 | 3749
9 | EXHIBIT 12.1 | ex121ceocertfication2017.htm | EX-12.1 | 13535
10 | EXHIBIT 12.2 | ex122cfocertification2017.htm | EX-12.2 | 12646
11 | EXHIBIT 13.1 | ex131ceocertification2017.htm | EX-13.1 | 7090
12 | EXHIBIT 13.2 | ex132cfocertification2017.htm | EX-13.2 | 5929
13 | EXHIBIT 15.1 | ex151-2017mda.htm | EX-15.1 | 414870
14 | EXHIBIT 15.2 | ex152eyconsentletter2017.htm | EX-15.2 | 4737
21 |  | eysignaturecpalpa.jpg | GRAPHIC | 14186
22 |  | figure1a06.jpg | GRAPHIC | 136092
23 |  | figure2a02.jpg | GRAPHIC | 162485
24 |  | oncolyticslogoblue.jpg | GRAPHIC | 341598
25 |  | oncolyticslogotaglineblue.jpg | GRAPHIC | 405809
| Complete submission text file | 0001129928-18-000028.txt |  | 9558148

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
15 | XBRL INSTANCE DOCUMENT | oncyf-20171231.xml | EX-101.INS | 1382585
16 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | oncyf-20171231.xsd | EX-101.SCH | 69421
17 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | oncyf-20171231_cal.xml | EX-101.CAL | 63109
18 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | oncyf-20171231_def.xml | EX-101.DEF | 216347
19 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | oncyf-20171231_lab.xml | EX-101.LAB | 623356
20 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | oncyf-20171231_pre.xml | EX-101.PRE | 368660

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-31062 | Film No.: 18699263
SIC: 2834 Pharmaceutical Preparations